
J
1.4K posts











A Georgia couple who terrorized a Black family at a child’s birthday party with Confederate flags, racial slurs, guns, and death threats were sentenced for a hate crime. Joe Torres got 20 years; Kyla Norton got 15..😳🚨


Fuentes is DONE with the immigration issue. We're already cooked! "If immigration is the only issue, I'm going back to bed!" 😂




The Vivek Files Chapter 1: Vivek's Fake Alzheimer's Dug While he was a member of the Soros Fellowship for New Americans, [1], Vivek Ramaswamy came up with a business idea. Drug companies need to test a lot of drugs, but only a few ever actually work. Vivek decided to buy failed drugs from reputable companies, find a way to make the drugs look like they work, and then cash out before the drugs failed FDA testing [2]. After a brief foray bankrolling Martin Shkreli, [3], Vivek decided to start his company and go dumpster diving for failed drugs. Vivek named his zombie drug company Roivant. With the ROI in the name standing for Return On Investment, [4], hardly the ideal goal for a pharmaceutical company. Vivek himself made no qualms that his goal was to make money in the drug industry, declaring that Roivant would be the “Berkshire Hathaway of drug development,” [5], and that “this will be the highest return on investment endeavor ever taken up in the pharmaceutical industry,” [6]. After a brief search of pharmaceutical failures, Vivek found an Alzheimer’s drug that “had already failed four consecutive mid-stage trials for Alzheimer’s disease,” [7], but “Ramaswamy insisted that if you squinted right, it appeared to work,” [8]. After failing at a real pharmaceutical company, the failed drug’s creator spent the next five years trying to find any company willing to buy the drug, [4]. Every company turned him down until Vivek showed up, [4]. Vivek immediately went on a media blitz, [9], hyping up his already-failed drug without producing “a single data point,” [4], before filing for a 9-figure IPO to “cash in fast on the still-sizzling market for biotech stocks,” [10]. Vivek then put his own mother in charge of testing his new drug, [11]. In fact, nearly half of Roivant’s employees were Ramaswamys at this point [12]. Shockingly, Vivek’s mom found that Vivek’s drug was working, [13] [14]. As the stock price took off based on people’s hope that Alzheimer’s had been cured, Vivek began cashing out to the tune of 10’s of millions of dollars, [15], while also reducing Roivant’s stake in their Alzheimer’s subsidiary company from 78% to 25%, [16]. This scheme was perhaps best explained by Jeffrey Sonnenfeld, Senior Associate Dean at Yale’s School of Management “... he [Vivek] was busy cashing out while shamelessly hyping Axovant’s prospects in media interviews–almost resembling a classic pump-and-dump scheme,” [17]. While Vivek “was busy cashing out,” [17], normal people got screwed. One large investor was a teacher’s pension fund. Vivek’s pump and dump scheme cost these people their retirement savings, [6]. Vivek’s phony Alzheimer’s drug company went from over $200/share during Vivek’s media blitz to out of business, costing investors their life savings, [18]. Vivek cashed out, investors got scammed, patients got screwed. @VivekGRamaswamy @DaveYostOH @RobertCSprague #h1b Citations [1] pdsoros.org/fellows/vivek-… [2] archive.is/pCNg4 [3] youtube.com/watch?v=Jr7zj4… [4] #google_vignette" target="_blank" rel="nofollow noopener">removepaywall.com/search?url=htt…
[5] newyorker.com/magazine/2022/… [6] nytimes.com/2023/06/27/us/… [7] biospace.com/why-former-med… [8] forbes.com/sites/nathanva… [9] youtu.be/75MY4Rr47WM?si… [10] fiercebiotech.com/biotech/financ… [11] fool.com/investing/2017… [12] sec.gov/Archives/edgar… [13] prnewswire.com/news-releases/… [14] ajgponline.org/article/S1064-… [15] s3.amazonaws.com/pdfs.taxnotes.… [16] archive.is/jzVj9 [17] removepaywall.com/search?url=htt… [18] finance.yahoo.com/news/sio-gene-…
.@VivekGRamaswamy is an outstanding communicator of our values. He believes in personal responsibility, meritocracy, & freedom. Yet ppl hate him bc…his parents are Indian immigrants. We can either commit suicide as a party, or we can eject the identitarians from our midst.

The Vivek Files Chapter 1: Vivek's Fake Alzheimer's Dug While he was a member of the Soros Fellowship for New Americans, [1], Vivek Ramaswamy came up with a business idea. Drug companies need to test a lot of drugs, but only a few ever actually work. Vivek decided to buy failed drugs from reputable companies, find a way to make the drugs look like they work, and then cash out before the drugs failed FDA testing [2]. After a brief foray bankrolling Martin Shkreli, [3], Vivek decided to start his company and go dumpster diving for failed drugs. Vivek named his zombie drug company Roivant. With the ROI in the name standing for Return On Investment, [4], hardly the ideal goal for a pharmaceutical company. Vivek himself made no qualms that his goal was to make money in the drug industry, declaring that Roivant would be the “Berkshire Hathaway of drug development,” [5], and that “this will be the highest return on investment endeavor ever taken up in the pharmaceutical industry,” [6]. After a brief search of pharmaceutical failures, Vivek found an Alzheimer’s drug that “had already failed four consecutive mid-stage trials for Alzheimer’s disease,” [7], but “Ramaswamy insisted that if you squinted right, it appeared to work,” [8]. After failing at a real pharmaceutical company, the failed drug’s creator spent the next five years trying to find any company willing to buy the drug, [4]. Every company turned him down until Vivek showed up, [4]. Vivek immediately went on a media blitz, [9], hyping up his already-failed drug without producing “a single data point,” [4], before filing for a 9-figure IPO to “cash in fast on the still-sizzling market for biotech stocks,” [10]. Vivek then put his own mother in charge of testing his new drug, [11]. In fact, nearly half of Roivant’s employees were Ramaswamys at this point [12]. Shockingly, Vivek’s mom found that Vivek’s drug was working, [13] [14]. As the stock price took off based on people’s hope that Alzheimer’s had been cured, Vivek began cashing out to the tune of 10’s of millions of dollars, [15], while also reducing Roivant’s stake in their Alzheimer’s subsidiary company from 78% to 25%, [16]. This scheme was perhaps best explained by Jeffrey Sonnenfeld, Senior Associate Dean at Yale’s School of Management “... he [Vivek] was busy cashing out while shamelessly hyping Axovant’s prospects in media interviews–almost resembling a classic pump-and-dump scheme,” [17]. While Vivek “was busy cashing out,” [17], normal people got screwed. One large investor was a teacher’s pension fund. Vivek’s pump and dump scheme cost these people their retirement savings, [6]. Vivek’s phony Alzheimer’s drug company went from over $200/share during Vivek’s media blitz to out of business, costing investors their life savings, [18]. Vivek cashed out, investors got scammed, patients got screwed. @VivekGRamaswamy @DaveYostOH @RobertCSprague #h1b Citations [1] pdsoros.org/fellows/vivek-… [2] archive.is/pCNg4 [3] youtube.com/watch?v=Jr7zj4… [4] #google_vignette" target="_blank" rel="nofollow noopener">removepaywall.com/search?url=htt…
[5] newyorker.com/magazine/2022/… [6] nytimes.com/2023/06/27/us/… [7] biospace.com/why-former-med… [8] forbes.com/sites/nathanva… [9] youtu.be/75MY4Rr47WM?si… [10] fiercebiotech.com/biotech/financ… [11] fool.com/investing/2017… [12] sec.gov/Archives/edgar… [13] prnewswire.com/news-releases/… [14] ajgponline.org/article/S1064-… [15] s3.amazonaws.com/pdfs.taxnotes.… [16] archive.is/jzVj9 [17] removepaywall.com/search?url=htt… [18] finance.yahoo.com/news/sio-gene-…


















